Stifel analysts confirmed their confidence in Clearpoint Neuro Inc. (NASDAQ:CLPT), maintaining a Buy rating and a price target of $17.00. The stock, currently trading at $17.85, has garnered strong ...
A Missouri jury has sided with two Springfield, Mo.-based physicians and their employers in a medical malpractice lawsuit brought by the widow of a man who died in 2022 from metastatic melanoma in his ...
Neurosurgery is a surgical procedure that uses invasive techniques to diagnose, investigate and/or treat a neurological disorder, disease or injury. For example, to remove a brain tumour or insert ...